Conference | Mixed
Event Title
Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development
May 29 - 30, 2024
- Date:
- May 29 - 30, 2024
- Day1:
- - ET
- Day2:
- - ET
Attend
Location
Hybrid
- In-Person at The Hotel @ the University of Maryland , College Park, MD
- Virtual via Adobe Connect
Attend In Person or Online
Click HERE for Onsite Attendance Information Details
Visit CDER Small Business and Industry Assistance Page
DRUGS, DEVICES, AND BIOLOGICS
TRACKS WILL OFFER AN OPPORTUNITY FOR 1:1 QUESTIONS ONSITE
Learn directly from the FDA’s regulatory experts in medical product centers: drugs, devices, and biologics. This course is designed to provide participants with a strong, basic foundation in the FDA’s regulatory requirements, and also create awareness of current activities.
Patrizia Cavazzoni M.D.
Director
Center for Drug Evaluation and Research (CDER)
Jeff Shuren M.D., J.D.
Director
Center for Devices and Radiological Health (CDRH)
Peter Marks M.D., PhD.
Director
Center for Biologics Evaluation and Research (CBER)
PLENARY
Innovation of medical products, whether it be drugs, devices, or biologics, is a continual journey that advances the needs of patients today and of future generations. Innovation takes the form in many spaces such as research, product design, data collection and analysis, and we’re currently bearing witness to a golden age of technology involving artificial intelligence and genomics. This session will provide a perspective of the current state at the FDA, both with current activities and what’s to come.
DRUGS TRACK DEVICES TRACK BIOLOGICS TRACK
CONTINUING EDUCATION
Real-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations. Certificates are only available during the two weeks post-event.
This course has been pre-approved by:
- RAPS as eligible for a maximum of 12 credits for a two-day event (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.
- SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate's clinical research therapeutic area.
- SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration.
- ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.
TECHNICAL INFORMATION
- To optimize your webinar experience, use Chrome when viewing Adobe Connect in a browser.
- Please contact info@sbiaevents.com for all technical questions.
- If you encounter any technical issues before or during the event, please visit the Technical Issues Support
- Test your PC for use with Adobe Connect prior to the day of the event. Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.